A Phase IIa clinical trial of cannabinoid-based therapeutic product, multilayer oral thin film (OTF), CureFilm™ in obstructive sleep apnea.
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Dronabinol/palmitoylethanolamide (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 16 Nov 2017 New trial record
- 07 Nov 2017 According to Cure Pharmaceutical media release, this phase IIa trial is initiated in obstructive sleep apnea.